TipRanks
Icu Medical (CH:IC7)
:IC7

ICU Medical (IC7) Price & Analysis

0 Followers

IC7 Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

Bulls Say, Bears Say

Bulls Say
Core Business GrowthRecord performance in pumps and consumables indicates broad demand across ICU Medical’s core product families rather than reliance on one offering. Strong pump activity can also support recurring administration-set and disposable sales, reinforcing the company’s hospital presence and revenue base.
Improving Margins And GuidanceHigher full-year EBITDA and gross-margin guidance signals that operational improvements are translating into stronger earnings capacity. If maintained, improved mix and efficiency can provide greater resilience against cost pressure while supporting reinvestment in products and commercial execution.
Cash Generation And DeleveragingPositive free cash flow gives ICU Medical internal funding capacity and enabled direct debt reduction during the quarter. Continued cash conversion and progress toward lower leverage should reduce financing pressure, improve balance-sheet flexibility, and support investment in strategic product programs.
Bears Say
Thin And Volatile ProfitabilityThe recent recovery has not yet established a consistently strong earnings profile. Thin margins and several years of losses make results more sensitive to execution, product mix, and cost changes, limiting confidence that current profitability will remain durable over the next several quarters.
Persistent Tariff BurdenTariffs represent a recurring cost headwind that can absorb a meaningful portion of operating improvement if pricing or productivity does not offset it. The annual burden may constrain margins and cash generation, making the earnings outlook more dependent on policy and cost recovery.
Ongoing Restructuring CostsFacility consolidation and integration expenses continue to consume cash and create earnings volatility while the operating footprint is being reshaped. Although these actions may eventually improve efficiency, ongoing charges reduce near-term conversion of revenue into dependable reported profit.

ICU Medical News

IC7 FAQ

What was Icu Medical’s price range in the past 12 months?
Currently, no data Available
What is Icu Medical’s market cap?
Icu Medical’s market cap is CHF3.34B.
    When is Icu Medical’s upcoming earnings report date?
    Icu Medical’s upcoming earnings report date is Nov 09, 2026 which is in 38 days.
      How were Icu Medical’s earnings last quarter?
      Icu Medical released its earnings results on Aug 06, 2026. The company reported CHF1.971 earnings per share for the quarter, beating the consensus estimate of CHF1.592 by CHF0.379.
        Is Icu Medical overvalued?
        According to Wall Street analysts Icu Medical’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Icu Medical pay dividends?
          Icu Medical does not currently pay dividends.
          What is Icu Medical’s EPS estimate?
          Icu Medical’s EPS estimate is 1.78.
            How many shares outstanding does Icu Medical have?
            Icu Medical has 25,007,038 shares outstanding.
              What happened to Icu Medical’s price movement after its last earnings report?
              Icu Medical reported an EPS of CHF1.971 in its last earnings report, beating expectations of CHF1.592. Following the earnings report the stock price went same N/A.
                Which hedge fund is a major shareholder of Icu Medical?
                Currently, no hedge funds are holding shares in CH:IC7
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Company Description

                  Icu Medical

                  ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.

                  ICU Medical (IC7) Earnings & Revenues

                  IC7 Company Deck

                  IC7 Earnings Call

                  Q2 2026
                  0:00 / 0:00
                  Earnings Call Sentiment|Positive
                  The call conveyed a positive operational and financial trajectory: record revenues in key businesses, margin expansion, raised full-year guidance, and strong free cash flow enabled a $50M debt paydown and progress toward a ~2x leverage target. Headwinds remain — notably tariffs, currency impacts, restructuring charges, and a weakened Vital Care reported performance due to JV deconsolidation — and there is some timing uncertainty around regulatory resubmissions and project phasing. On balance, the company emphasized momentum and achievable margin/cash goals despite macro and one-time pressures.View all CH:IC7 earnings summaries

                  IC7 Stock 12 Month Forecast

                  Average Price Target

                  ―
                  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
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  AngioDynamics
                  ―
                  ―
                  Baxter International
                  ―
                  ―
                  Becton Dickinson
                  ―
                  ―
                  Merit Medical Systems
                  ―
                  ―
                  Teleflex
                  ―
                  ―
                  Popular Stocks